GeneMatrix (109820) Stock Overview

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections. It also provides vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement or treatment. The company was founded in 2000 and is headquartered in Seongnam, South Korea.